Priyanka A Pophali1,2, Melissa C Larson3, Cristine Allmer3, Umar Farooq4, Brian K Link4, Matthew J Maurer3, James R Cerhan3, Carrie A Thompson5. 1. Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA. 2. Division of Hematology, Oncology and Palliative Care, Department of Medicine, University of Wisconsin, Madison, WI, USA. 3. Department of Health Sciences Research, Mayo Clinic, Rochester, MN, USA. 4. Division of Hematology, Oncology and Bone and Marrow Transplantation, University of Iowa, Iowa City, IA, 52242, USA. 5. Division of Hematology, Department of Internal Medicine, Mayo Clinic, Rochester, MN, USA. Thompson.Carrie@mayo.edu.
Abstract
PURPOSE: Compliance with US Preventive Services Task Force (USPSTF) age-appropriate cancer screening and immunization guidelines in lymphoma survivors is not known. We sought to measure compliance in non-Hodgkin lymphoma (NHL) survivors and identify any differences based on patient, disease, and treatment characteristics. METHODS: Eligible NHL survivors were identified from the Molecular Epidemiology Resource (MER) prospective cohort study. Survivors self-reported colorectal, breast, and prostate cancer screening and influenza immunization in a questionnaire 3 years post-diagnosis (FU3). The USPSTF guidelines were used to define compliance. Chi-square tests were used to compare characteristics of compliant versus non-compliant survivors. RESULTS: A total of 1833 MER participants from 2005 to 2012 completed a FU3. Rates of breast and prostate cancer screening were 96% and 72%, respectively. No differences in compliance based on patient or disease characteristics or treatment were observed. Ninety-two percent of survivors were compliant with colorectal cancer screening. Older age, indolent lymphoma histology, and 2008-2012 year of diagnosis were associated with higher compliance. Eighty-two percent of survivors were compliant with influenza vaccination and older age was associated with higher compliance. CONCLUSION: NHL survivors have high compliance with USPSTF recommendations for cancer screening and immunization. Survivors who are younger or have aggressive lymphomas are less likely to meet the colorectal cancer screening guidelines. Older survivors are more likely to receive influenza vaccination. IMPLICATIONS FOR CANCER SURVIVORS: Measures to further improve preventive care for NHL survivors, especially those younger in age, are necessary.
PURPOSE: Compliance with US Preventive Services Task Force (USPSTF) age-appropriate cancer screening and immunization guidelines in lymphoma survivors is not known. We sought to measure compliance in non-Hodgkin lymphoma (NHL) survivors and identify any differences based on patient, disease, and treatment characteristics. METHODS: Eligible NHL survivors were identified from the Molecular Epidemiology Resource (MER) prospective cohort study. Survivors self-reported colorectal, breast, and prostate cancer screening and influenza immunization in a questionnaire 3 years post-diagnosis (FU3). The USPSTF guidelines were used to define compliance. Chi-square tests were used to compare characteristics of compliant versus non-compliant survivors. RESULTS: A total of 1833 MER participants from 2005 to 2012 completed a FU3. Rates of breast and prostate cancer screening were 96% and 72%, respectively. No differences in compliance based on patient or disease characteristics or treatment were observed. Ninety-two percent of survivors were compliant with colorectal cancer screening. Older age, indolent lymphoma histology, and 2008-2012 year of diagnosis were associated with higher compliance. Eighty-two percent of survivors were compliant with influenza vaccination and older age was associated with higher compliance. CONCLUSION:NHL survivors have high compliance with USPSTF recommendations for cancer screening and immunization. Survivors who are younger or have aggressive lymphomas are less likely to meet the colorectal cancer screening guidelines. Older survivors are more likely to receive influenza vaccination. IMPLICATIONS FOR CANCER SURVIVORS: Measures to further improve preventive care for NHL survivors, especially those younger in age, are necessary.
Entities:
Keywords:
Cancer screening; Immunization; NHL survivors
Authors: Laura P Forsythe; Neeraj K Arora; Catherine M Alfano; Kathryn E Weaver; Ann S Hamilton; Noreen Aziz; Julia H Rowland Journal: Support Care Cancer Date: 2014-01-12 Impact factor: 3.603
Authors: G Sanna; K Lorizzo; N Rotmensz; V Bagnardi; S Cinieri; M Colleoni; F Nolè; A Goldhirsch Journal: Ann Oncol Date: 2006-11-06 Impact factor: 32.976
Authors: Andrea K Ng; Judy E Garber; Lisa R Diller; Robyn L Birdwell; Yang Feng; Donna S Neuberg; Barbara Silver; David C Fisher; Karen J Marcus; Peter M Mauch Journal: J Clin Oncol Date: 2013-04-22 Impact factor: 44.544
Authors: Lorry G Rubin; Myron J Levin; Per Ljungman; E Graham Davies; Robin Avery; Marcie Tomblyn; Athos Bousvaros; Shireesha Dhanireddy; Lillian Sung; Harry Keyserling; Insoo Kang Journal: Clin Infect Dis Date: 2014-02 Impact factor: 9.079
Authors: Kimberly D Miller; Rebecca L Siegel; Chun Chieh Lin; Angela B Mariotto; Joan L Kramer; Julia H Rowland; Kevin D Stein; Rick Alteri; Ahmedin Jemal Journal: CA Cancer J Clin Date: 2016-06-02 Impact factor: 508.702